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Amino acids are the most abundant neurotransmitters in the brain. 
Neurotransmitters are synthesized and stored in presynaptic terminals, released 
from terminals upon stimulation with specific receptors on the postsynaptic cells. 
Chemical and electrical synapses are specialized biological structures found in 
the nervous system; they connect neurons together and transmit signals across 
the neurons. The process of synaptic transmission generates or inhibits electrical 
impulses in a network of neurons for the processing of information. Glutamate is 
the primary excitatory neurotransmitter in the brain, while GABA is the principal 
inhibitory neurotransmitter. The balance of glutamatergic and GABAergic tone is 
crucial to normal neurologic function. Through synaptic transmission, this informa-
tion is communicated from the presynaptic cell to the postsynaptic cell. Amino acid 
neurotransmitters primarily glutamic acid, GABA, aspartic acid, and glycine are 
single amino acid residues released from presynaptic nerve terminals in response 
to an action potential and cross the synaptic cleft to bind with specific receptor on 
the postsynaptic membrane. The integral role of amino acid neurotransmitters is 
important on the normal functioning of the brain. The presynaptic and postsynaptic 
events in chemical synapses are subject to use dependent and highly regulated as per 
the changes in synaptic neurotransmitter release and function.
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1. Introduction
The nervous system is composed of billions of specialized cells called neurons. 
Neurons are the cells of chemical communication in the brain. In its most basic 
form, a neuron has two ends (although either can have multiple branches): an axon 
and a dendrite (Figure 1). Efficient communication between neuronal cells is a 
crucial process for the normal functioning of the central and peripheral nervous 
system. Neurotransmitters are chemical substances that act as the mediator for 
the transmission of nerve impulses from one neuron to another neuron through 
synapses. Neurotransmitters are stored in the axon (or presynaptic neuron) in 
little packages called synaptic vesicles. The release of neurotransmitter is triggered 
by the arrival of nerve impulse (or action potential). Synapses are specialized 
junctions through which cells of the nervous system signal to one another and to 
non-neuronal cells such as muscles or glands. The process by which the information 
is communicated through synapse is called synaptic transmission [1, 2].
The neurotransmitters are stored in the vesicles within the presynaptic nerve 
terminal at the synaptic membrane of one nerve cell and released into the synaptic 
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cleft in response to nerve impulses [2]. The secreted neurotransmitters can then 
act on receptors on the membrane of the postsynaptic neuron through a gap called 
synaptic gap (0.02 micron). The number of synaptic contacts of an average neuron 
is approximately 10,000. Thus, there are 3–5 × 1015 synapses in the human brain. 
There are two types of synapses, electrical and chemical synapses, but chemical 
synapses (Figure 2) far outnumber electrical ones. Electric synapses are gap junc-
tion. A gap junction is a junction between neurons that allows different molecules 
and ions to pass freely between cells. The junction connects the cytoplasm of cells. 
A gap junction is composed of connexons (each connexon is composed of six con-
nexin proteins) which connect across the intercellular space. Neurons connected 
by gap junctions sometimes act as though they were equivalent to one large neuron 
with many output pathways, all of which fire synchronously.
Synapses are made on all regions of a receiving nerve cell and can be classified 
on the basis where they are located. On spiny dendrites of a nerve cell, each spine is 
the target of an axon terminal and comprises the postsynaptic component of a single 
synapse. Synapses between axons and dendrites are called axodendritic. Particularly 
powerful synapses are made between axons of one neuron and cell body of another 
postsynaptic cell. These are called axosomatic synapses. Synapses between axon 




Structure of chemical and electrical synapse.
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Substances that act as neurotransmitters can be categorized into different 
groups. The three major categories of substances that act as neurotransmitters are:
1. Amino acids: The neurotransmitters of this group are involved in fast synaptic 
transmission and are inhibitory and excitatory in action (primarily glutamic 
acid, GABA, aspartic acid, and glycine).
2. Amines: Amines are the modified amino acids such as biogenic amines, e.g., 
catecholamines. The neurotransmitters of this group involve in slow synaptic 
transmission and are inhibitory and excitatory in action (noradrenaline, 
adrenaline, dopamine, serotonin, and histamine).
3. Others: The one which do not fit in any of these categories (acetyl choline and 
nitric oxide). Amino acids are among the most abundant of all neurotransmit-
ters present within the central nervous system (CNS).
Several amino acids have been implicated as neurotransmitters in the CNS, 
including GABA, glutamic acid, glycine, and aspartic acid [3]. Some (like glu-
tamate) are excitatory, whereas others (like GABA) are primarily inhibitory. 
Aspartate is closely related to glutamate, and the two amino acids are often are 
found together at axon terminals. Neurons synthesize glutamate and aspartate and 
are independent of dietary supply.
1.1 Function of amino acid neurotransmitter
The amino acid neurotransmitters are common neurotransmitters in the central 
nervous system. Glycine, glutamate, and GABA are classed under amino acid neu-
rotransmitter. The two amino acids functioning as excitatory neurotransmitter are 
glutamate and aspartate. GABA acts as a brake to the excitatory neurotransmitters, 
and thus when it is abnormally low, this can lead to anxiety, and glutamate usually 
ensures homeostasis with the effects of GABA [4]. Several related amino acids, like 
homocysteic acid and N-acetylaspartylglutamate, may also serve a neurotransmit-
ter function. Neurotransmitters can be classified as either excitatory or inhibitory. 
Excitatory neurotransmitters function to activate the receptors on the postsynaptic 
membrane and enhance the effects of action potential, while inhibitory neurotrans-
mitter functions in a reverse mechanism. If the electrical impulses transmitted 
inward toward the cell body are large enough, they will generate an action potential.
The action potentials are caused by an exchange of ions across the neuron 
membrane; a stimulus first causes sodium channels to open, because there are many 
more sodium ions on the outside, and the inside of the neuron is negative relative to 
the outside; sodium ions rush into the neuron. Since sodium has a positive charge, 
the neuron becomes more positive and becomes depolarized. It takes longer for 
potassium channels to open; when they do open, potassium rushes out of the cell, 
reversing the depolarization. Also at about this time, sodium channels start to 
close; this causes the action potential to go back toward −70 mv (a repolarization). 
The action potential actually goes past (overshoots) −70 mv (a hyperpolarization) 
because the potassium channels stay open a bit too long. Gradually, the ion concen-
trations go back to resting levels, and the cell returns to −70 mv.
The action potential is produced by an influx of calcium ions through voltage-
dependent calcium-selective ion channels. Calcium ions then trigger a biochemical 
cascade which results in neurotransmitter vesicles fusing with the presynaptic 
membrane and releasing their contents to the synaptic cleft. Receptors on the 
opposite side of the synaptic gap bind neurotransmitter molecules and respond 
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by opening nearby ion channels in the postsynaptic cell membrane, causing ions 
to rush in or out and changing the local transmembrane potential of the cell. The 
resulting change in voltage is called a postsynaptic potential. The result is excit-
atory, in the case of depolarizing currents, or inhibitory in the case of hyperpolar-
izing currents resulting in EPSP or IPSP, respectively (Figure 3).
Whether a synapse is excitatory or inhibitory depends on what type(s) of ion 
channel conduct the postsynaptic current, which in turn is a function of the type of 
receptors and neurotransmitter employed at the synapse. Neurotransmitters may 
have excitatory effects if they drive a cell’s membrane to the threshold of an action 
potential (Figure 4).
The resting potential of a neuron tells about what happens when a neuron is at 
rest. An action potential occurs when a neuron sends information down an axon, 
away from the cell body. The action potential is an explosion of electrical activity 
that is created by a depolarizing current. This means that a stimulus causes the rest-
ing potential to move toward 0 mv.
1. When the depolarization near the axon hillock reaches about −55 mv as a 
result of summation of EPSPs, a neuron will fire an action potential. This is 
the threshold. If the neuron does not reach this critical threshold level, then no 
action potential will fire.
2. Also, when the threshold level is reached, an action potential of a fixed sized 
will always fire for any given neuron; the size of the action potential is always 
the same.
There are no big or small action potentials in one nerve cell. All action potentials 
are the same in size in a particular neuron type (it can differ between different types 
of neurons). Therefore, either the neuron does not reach the threshold or a full 
action potential is fired—this is the “all or none” principle.
Figure 3. 
EPSP and IPSP on a neuron.
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A neuron encodes the intensity of a stimulus in the frequency of firing 
and not in the size of a single impulse. Neurotransmitters may have inhibitory 
effects if they help to drive the membrane away from threshold. An excitatory 
postsynaptic potential (EPSP) is a summation of signals that brings the mem-
brane closer to the threshold (depolarizing effect). An inhibitory postsynaptic 
potential (IPSP) drives the membrane away from threshold by a hyperpolarizing 
effect.
1.1.1 Excitatory neurotransmitters
An excitatory postsynaptic potential (EPSP) is a temporary increase in post-
synaptic membrane potential within dendrites or cell bodies caused by the flow of 
sodium ions into the postsynaptic cell. EPSPs are additive. Larger EPSPs result in 
greater membrane depolarization and thus increase the likelihood that the post-
synaptic cell reaches the threshold for firing an action potential. When an active 
presynaptic cell releases neurotransmitters into the synapse, some of them bind to 
receptors on the postsynaptic cell. Many of these receptors contain an ion channel 
capable of passing positively charged ions either into or out of the cell. At excit-
atory synapses, the ion channel typically allows sodium into the cell, generating an 
excitatory postsynaptic current.
1.1.2 Inhibitory neurotransmitters
GABA and glycine are inhibitory, both instead of depolarizing the postsynaptic 
membrane and producing an EPSP; they hyperpolarize the postsynaptic mem-
brane and produce IPSP. IPSP is the change in membrane voltage of a postsynaptic 
neuron which results from synaptic activation of inhibitory neurotransmitter 
receptors. The most common inhibitory neurotransmitters in the nervous system 
are γ-aminobutyric acid (GABA) and glycine. At a typical inhibitory synapse, the 
postsynaptic neural membrane permeability increases for K+ ions and Cl− ions but 
not for Na+ ions.
This generally causes an influx of chloride ions and efflux of K+ ions, thereby 
bringing the membrane potential closer to the equilibrium potential of these ions.
Figure 4. 
Action potential.
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2. Amino acid neurotransmitters
Amino acid transmitters provide the majority of excitatory and inhibitory 
neurotransmission in the nervous system. Amino acids used for synaptic transmis-
sion are compartmentalized (e.g., glutamate, compartmentalized from metabolic 
glutamate used for protein synthesis by packaging the transmitter into synaptic 
vesicles for subsequent Ca2+-dependent release). Amino acid neurotransmitters are 
all products of intermediary metabolism with the exception of GABA. Unlike all 
the other amino acid neurotransmitters, GABA is not used in protein synthesis and 
is produced by an enzyme (glutamic acid decarboxylase; GAD) uniquely located in 
neurons. Antibodies to GAD can be used to identify neurons that release GABA.
2.1 Glutamate
Glutamate is used at the great majority of fast excitatory synapses in the brain and 
spinal cord. Glutamatergic neurons are particularly prominent in the cerebral cortex. 
They project to a variety of subcortical structures like the hippocampus, the basolateral 
complex of the amygdala, the substantia nigra, the nucleus accumbens, the superior 
colliculus, the caudate nucleus (nucleus ruber), and the pons. At glutamatergic synapses, 
NMDA receptors (NMDARs) are localized with other ionotropic glutamate receptors 
[AMPA receptors (AMPARs) and kainate receptors] and with metabotropic glutamate 
receptors. Glutamate receptors are necessary for neuronal development, synaptic 
plasticity, excitotoxicity, pain perception, and learning and memory [5]. Among these 
EPSP-producing glutamate receptors, which could occur as homomeric or heteromeric 
structures, are classified according to the binding of the most common agonist [6].
Four subtypes can be distinguished, out of which three are ionotropic receptors 
and one metabotropic receptor, activated by quisqualate. These are named accord-
ing to the molecules (other than glutamate) that they bind and include:
1. NMDA receptors (named for N-methyl-D-aspartate)
2. AMPA receptors (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate)
3. Kainate receptors
4. Receptors which are activated by quisqualate
2.1.1 NMDA receptors
NMDA receptor is very important for controlling developmental synaptic plas-
ticity and learning and memory function. NMDARs have critical roles in excitatory 
synaptic transmission, plasticity, and excitotoxicity in the CNS (Figure 5). The 
NR1 subunit is evenly expressed in most of the brain, but the NR2 subunit (NR2A, 
NR2B, NR2C, and NR2D) shows distinct regional distributions [6, 7]. NMDA 
receptors show three specific properties by which they differ from other types of 
ionotropic receptors:
a. NMDA receptor ion channel is subjected to voltage-dependent block by the 
extracellular Mg2+ ion.
b. They display a high permeability to Ca2+ ions. Ca2+ influx through NMDA 
receptor channel leads to a cascade of intracellular events triggering long-term 
potentiation (LTP) and long-term depression (LTD) of synaptic currents.
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c. The response of NMDA receptor to neurotransmitter like glutamate and glycine 
under physiological conditions is modified by certain extracellular molecules 
like H+, Zn2+, and polyamines. Most of the NMDA receptors function only in 
heteromeric assemblies, composed of two NR1 and two NR2 subunits.
Glutamate binds to the S1 and S2 regions of NR2 subunit, whereas glycine binds 
to the S1 and S2 regions of NR1 subunit. Individual NR1 or NR2 subunits contain an 
extracellular N terminus which forms S1, an intracellular C terminus, and an extra-
cellular loop between M3 and M4 that constitutes S2. The channel lining domain 
is formed by a reentrant pore loop called as M2 loop that enters the channel from 
the cytoplasmic side and forms a narrow constriction at that channel. The critical 
asparagine residue located within M2 loop determines the selectivity of NMDAR 
channel for Mg2+ block and Ca2+ permeability.
The function of NMDA receptors is totally dependent upon AMPA receptors. In the 
absence of AMPA, NMDA is initially expressed, and it forms the silent synapse. The 
NMDA receptors are not activated unless the postsynaptic region is depolarized by AMPA 
receptors.
AMPA receptors are ionotropic and belong to the group of non-NMDA receptors 
and associated with a cation-selective ion channel which is permeable for monova-
lent cations, like Na+ and K+. Under certain combinatorial conditions of the receptor 
subunits, it also becomes permeable to Ca2+.
Kainate receptors can be activated by kainite and glutamate. Like AMPA recep-
tors, the kainite receptors are associated with an ionic channel which is permeable 
for the monovalent cations Na+ K+ and for Ca2+. These receptors are mainly involved 
in modulating the release of excitatory amino acids and additional neurotransmit-
ters or neuromodulators.
The metabotropic receptors are activated by glutamate and quisqualate and 
resistant to activation by NMDA, AMPA, or kainate.
2.2 GABA
GABA is the most ubiquitous inhibitory neurotransmitter in the brain. GABA 
was discovered in 1883, and its inhibitory function was described in the late 1950s 
by Bazemore et al. [8]. It was the first amino acid to be established as a neurotrans-
mitter in vertebrate and invertebrate nervous systems. GABA is synthesized in 
nervous tissue exclusively from glutamate by the alpha decarboxylation of glutamic 
Figure 5. 
NMDA receptor.
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acid in the presence of glutamic acid decarboxylase (GAD). The apparent promi-
nent role of GAD in modulation of GABA levels becomes obvious under pathologi-
cal conditions, where GAD concentration can differ significantly from normal 
levels.
Striatum contained nearly 95% of the cells which are GABAergic. GABA is also 
suspected to operate as an inhibitory neurotransmitter in the cerebral cortex, lateral 
vestibular nucleus, and spinal cord.
2.2.1 GABA receptors
GABA exerts its effects via ionotropic (GABAA) and metabotropic (GABAB) 
receptors. GABAA receptors show a ubiquitous distribution throughout the CNS 
and have been identified on both neuron and glia. GABA can act on both rapid and 
slow inhibitory receptors (the GABAA and GABAB), respectively. GABAA receptors 
are chloride channels that in response to GABA binding increases chloride influx 
into the neuron. The agonist of these receptors includes GABA and muscimol. The 
GABAB receptors are potassium channels that when activated by GABA leads to 
potassium efflux from the cell. GABAA receptors are ionotropic receptors leading to 
increased Cl− ion conductance, whereas GABAB receptors are metabotropic recep-
tors which are coupled to G proteins and thereby indirectly alter membrane ion 
permeability and neuronal excitability [4].
2.3 Glycine
Glycine is the simplest of amino acids, consisting of an amino group and a 
carboxyl (acidic) group attached to a carbon atom. In mammals, glycine belongs to 
the nonessential amino acids [9]. Until the early 1960s, glycine was of minor impor-
tance in synaptic transmission because of its simple structure and its ubiquitous 
distribution as a member of protein and nucleotide metabolism. Glycine’s function 
is a potent neurotransmitter in the spinal cord and brain. Glycine is a constituent 
of glutathione, an antioxidant tripeptide found in high concentrations in intestinal 
epithelial cells. The availability of glycine has the potential to control the cellular 
levels of glutathione in enterocytes. This amino acid functions as an excitatory trans-
mitter during embryonic development and is an essential coagonist at glutamatergic 
synapses containing the NMDA subtype of glutamate receptors. Hydroxymethyl 
transferase converts the amino acid serine to glycine. More recently, glycine has been 
found to play a role in the functional modulation of NMDA receptors.
2.3.1 Glycine receptor
Glycine receptors are ligand-gated ion channels that increase Cl− influx. 
Glycine molecules may be taken back into the presynaptic cell by two high-
affinity glycine transporters (Glyt-1 and Glyt-2). Glyt-1 is found primarily in glial 
cells, whereas Glty-2 is found primarily in neuronal cells. The transport of glycine 
via Glyt-1 is coupled to the movement of Na+ and Cl−, with a Na+:Cl−:glycine 
stoichiometry of 2:1:1.
The glycine receptor GlyR belongs to the superfamily of ligand-gated ion 
channels, like GABAA, and is primarily found in the ventral spinal cord. Strychnine 
is a glycine antagonist which can bind to the glycine receptor without opening the 
chloride ion channel (i.e., it inhibits inhibition). GlyR is a strychnine-sensitive 
glycoprotein which is composed of five subunits. The receptor has a pentameric 
structure with three ligand-binding α subunits and two β subunits forming an ion 
channel. This heterogenicity is responsible for the distinct pharmaceutical and 
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functional properties displayed by the various receptor configurations that are 
differentially expressed and assembled during development [10].
The glycine receptor is presently considered to form a complex consisting of 
a glycine recognition site and an associated chloride channel. Hyperekplexia, or 
startle disease, is a rare neurological disorder characterized by an exaggerated 
response to unexpected stimuli. The response is typically accompanied by a tran-
sient but complete muscular rigidity (stiff baby syndrome).
2.4 Aspartate
Glutamate and aspartate are nonessential amino acids that do not cross the 
blood-brain barrier and, therefore, are synthesized from glucose and a variety of 
other precursors. The synthetic and metabolic enzymes for glutamate and aspartate 
have been localized to the two main compartments of the brain, neurons and glial 
cells. Aspartate is the most abundant excitatory neurotransmitter in the CNS. Like 
glycine, aspartate is primarily localized to the ventral spinal cord. Like glycine, 
aspartate opens an ion channel and is inactivated by reabsorption into the presyn-
aptic membrane. Unlike glycine, however, aspartate is an excitatory neurotransmit-
ter, which increases the likelihood of depolarization in the postsynaptic membrane 
[9, 10]. Aspartate is a highly selective agonist for NMDAR-type glutamate receptors 
and does not activate AMPA-type glutamate receptors. Hence, synapses only 
releasing aspartate should therefore generate only NMDAR currents despite a full 
postsynaptic complement of AMPARs [11].
Aspartate and glycine form an excitatory/inhibitory pair in the ventral spinal 
cord comparable to the excitatory/inhibitory pair formed by glutamate and GABA 
in the brain. Interestingly, the two excitatory amino acids, glutamic acid and 
aspartic acid, are the two acidic amino acids found in proteins, insofar as both have 
two carboxyl groups rather than one. Thus, variation in the vesicular content of 
glutamate and aspartate might have a profound effect on the relative contribution of 
NMDARs and AMPARs to synaptic transmission [12, 13].
3. Conclusion
Neurotransmitters are the brain chemicals that communicate information 
throughout our brain and body. They relay signals between neurons. Amino acid 
neurotransmitters can be subdivided into the excitatory amino acids aspartate and 
glutamate and the inhibitory amino acids GABA and glycine. Common inhibitory 
neurotransmitters such as GABA and glycine calm the brain and help create bal-
ance, whereas excitatory neurotransmitters such as glutamate and aspartate stimu-
late the brain.
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